Exposed: Democrats' Secret Plan to Keep Trump Out of the White House

Former advisor to the CIA, the Pentagon and the White House Jim Rickards just released this shocking new video exposing Democrats' secret plan to keep Trump out of the White House... Even if he wins the election. See the details and learn how to prepare... Because this could trigger the biggest constitutional crisis in our nation's history.

Popular

WHO and Africa CDC launch a response plan to the mpox outbreak

DAKAR, Senegal (AP) — The Africa Center for Disease Control and Prevention and the World Health Organization launched on Friday a continent-wide response plan to the outbreak of mpox, three weeks after WHO declared outbreaks in 12 African countries a .

Forget AI, Imperium Is Expected to Grow 320,000% In 3 Years - Ad

Three of the world's biggest AI companies -- Google, Nvidia and Intel -- have even partnered with my No. 1 Imperium company to get on this massive mega trend. The average investor hasn't caught on yet, but you can still invest in my No. 1 Imperium company for just $10 a share.

Treasury recovers $1.3 billion in unpaid taxes from high wealth tax dodgers

WASHINGTON (AP) — The IRS has collected $1.3 billion from since last fall, the agency announced Friday, crediting spending that has ramped up collection enforcement through President Joe Biden's signature signed into law in 2022.

September 23 - The Biggest Crypto Event in History - Ad

According to the man who called every major market top and bottom for the last 29 years... A single event triggering on September 23rd will send the crypto market soaring. But what's more exciting... is that this event could send a small sector of the crypto market soaring 5X, 25X, and even 100X higher in just days.

Fortified bouillon cubes are seen as a way to curb malnutrition in Africa as climate worsens hunger

IBADAN, Nigeria (AP) — In her cramped, dimly lit kitchen, Idowu Bello leans over a gas cooker while stirring a pot of eba, the thick starchy West African staple made from cassava root. Kidney problems and chronic exhaustion forced the 56-year-old Nigerian woman to retire from teaching, and she switches between cooking with gas or over a wood fire depending on the fuel she can afford.

Eli Lilly Scores FDA Approval For Eczema Treatment Ebglyss

The FDA has approved Eli Lilly's Ebglyss for moderate-to-severe eczema in patients 12 and older. The treatment is administered via monthly injections and demonstrated clear skin and itch relief in clinical trials.

A New Drug Set to Outgrow Zoloft and Metformin--Invest Now - Ad

A new breakthrough drug is predicted to hit 250 million subscriptions in the next SIX YEARS, according to Morgan Stanley. Even better, a tiny company - trading for only $7 - holds key patents on this new drug. But it won't stay under the radar for much longer.

Moderna Faces Analyst Downgrades Amid Revised R&D Restructured Strategy and Delayed Profitability Target

Moderna announces plans to reduce R&D spending by $1.1 billion by 2027, focusing on ten key products. Analysts highlight near-term challenges, lowered price targets, and a delayed breakeven to 2028, with optimism around Moderna's oncology pipeline and long-term platform potential.

Congress targets Chinese influence in health tech. It could come with tradeoffs

WASHINGTON (AP) — A California that helps doctors detect genetic causes for cancer is among those that could be cut out of the U.S. market over ties to China, underscoring the possible tradeoffs between health innovation and a to counter Beijing's global influence.

Oil Surge Predicted...But Are You Ready? - Ad

Do you own oil and gas stocks? Or are you thinking about buying some? If so, you need to see my #1 oil play for 2024. But it's NOT oil stocks, futures, or anything you've likely heard about. Rather, it's an unusual way to potentially bank monthly income from the oil and gas markets.

How social media became a storefront for fake pills as families struggle

Fentanyl overdoses have become for minors in the last five years or so, even as overall drug use has dropped slightly. In a 2022 analysis of fentanyl-laced prescription pills, the contained a potentially lethal dose of the drug.

Could America's divide on marijuana be coming to an end?

The U.S. is divided when it comes to state and federal marijuana policy, but recent political developments could move the country toward a greater acceptance of cannabis.

A 10,000% Dividend?!? - Ad

Have you seen this strange oil investment? It's NOT a stock, bond, or private company...It has NO age requirements...You do NOT need to be accredited to participate... And you can get in for as little as $25.

Viking Therapeutics Stock Could Soar 45% Ahead Of Key Weight Loss Drug Readout: JPMorgan

JPMorgan analyst Hardik Parikh initiated coverage on Viking Therapeutics with an Overweight rating and a December 2025 price target of $80.

Stryker Unveils New Foot & Ankle Solutions With Truss Implants: Details

Stryker Corporation announced new Foot & Ankle products from 4WEB Medical, with analysts maintaining positive ratings.

Oil = Monthly Income - Ad

Right now, there's an unusual $25 way to collect MONTHLY income from the oil markets. It's not a stock, bond, or anything you've likely heard about... But it's by far my #1 investment opportunity for 2024.

Limits to anti-nausea pill coverage wear on cancer patients and doctors

Cancer patients can ward off waves of vomiting after treatment with a relatively cheap anti-nausea pill, but some are running into coverage limits.

Seven Unknown AI Stocks That Could Dominate the Next Six Years - Ad

The original "Magnificent Seven" stocks generated 16,800% over the last 20 years. But now a new set of AI stocks is set to take over. Alex Green dubs them "The Next Magnificent Seven." And he's arguing that just $1,000 in each could turn into more than $1 million in less than six years.

Workers take their quest to ban smoking in Atlantic City casinos to a higher court

ATLANTIC CITY, N.J. (AP) — Workers seeking to ban smoking in Atlantic City's casinos on Friday asked an appeals court to consider their request, saying a lower court judge who dismissed their lawsuit did so in error.

Bicycle Therapeutics' Lead Cancer Candidate's Has High-Opportunity, Analyst Initiates With Bullish Tone

RBC Capital initiates coverage on Bicycle Therapeutics, highlighting Zelenectide's potential in oncology with improved safety over competitors. The analyst projects ~$2 billion in peak sales by 2033 and sees opportunities beyond metastatic urothelial cancer.

My No. 1 Oil Play for 2024 - Ad

Do you own oil and gas stocks? Or are you thinking about buying some? If so, you need to see my #1 oil play for 2024. But it's NOT oil stocks, futures, or anything you've likely heard about. Rather, it's an unusual way to potentially bank monthly income from the oil and gas markets.

Teen vaping hits 10-year low in the US

WASHINGTON (AP) — Fewer adolescents are this year than at any point in the last decade, government officials reported Thursday, pointing to a of high school students who are using Elf Bar and other fruity, unauthorized e-cigarettes.

America's Slow Decline into Hell - Ad

As Kamala Harris rises to power, her 3-word agenda threatens every American's freedom and financial security. Get the inside scoop and

Steward CEO says he won't comply with Senate subpoena on hospital closings

BOSTON (AP) — Steward Health Care CEO Ralph de la Torre won't comply with a subpoena to appear before a U.S. Senate committee that is investigating the hospital company's bankruptcy, his lawyers said Wednesday.

Sanofi Still Bets On Multiple Sclerosis Med Tolebrutinib Despite The Investigational Drug Fell Short In 2 Of 3 Phase 3 Trials

Sanofi's phase 3 HERCULES study data shows tolebrutinib met the primary endpoint in delaying disability progression in non-relapsing secondary progressive multiple sclerosis.

'Wake-and-Bake' Cannabis Use Rising Among Young Adults To Cope With Social Anxiety, Unaware Of Risks

Wake-and-bake cannabis use among young adults is rising as a way to cope with anxiety, but it carries significant risks that need attention.

Judge's Early Ruling May Shape Outcome In Ozempic, Wegovy Lawsuits

A Philadelphia judge's early ruling in the Ozempic and Wegovy litigation may shape the outcome of the lawsuits against Novo Nordisk and Eli Lilly, focusing on the diagnosis of gastroparesis and the adequacy of drug warnings.

Could You Retire on a Single AI Stock (Trading for Only $15)? - Ad

Imagine what the perfect AI stock would look like...forefront of AI trend...virtual monopoly in its market... exempt from federal taxes. As you're about to see, this perfect AI stock does exist, and is currently trading for only $15. With just one investment, you could potentially set yourself up for massive financial gains.

Fed Health Agency Funds $2.4M Study On Psychedelics Treatment For Meth Addiction

NIH awards $2.4M to study psychedelics as a potential treatment for methamphetamine addiction, aiming to uncover new therapeutic approaches.

Jazz And Hikma Accused Of Delaying Sleep Disorder Generic Drug To Maintain High Prices

Jazz Pharmaceuticals and Hikma Pharmaceuticals will face trial over allegations of delaying a generic version of Xyrem, causing higher drug prices. Plaintiffs accuse Jazz of antitrust violations and claim the company raised Xyrem's price by over 800%.

U.S. Loses to China in Shocking WAR GAMES - Ad

Pentagon says new "living missile" key to winning a future conflict. Investors stand to reap 35,960% on shares of the small defense contractor that makes powerful new weapon.

Montana doctor overprescribed meds and overbilled health care to pad his income, prosecutors say

HELENA, Mont. (AP) — A Montana cancer doctor for years saw up to 70 patients a day, double-billed federal health care programs and overprescribed pain medications to boost his income, the U.S. Attorney's Office said Tuesday while announcing a civil lawsuit against him and a $10.8 million settlement with the hospital where he worked.

Governments Suing Pharmacy Benefit Managers Over Insulin Prices Have Long Benefited From Their Rebates

State and local governments suing PBMs and drug companies over insulin prices have long benefited from the same rebate system they now criticize, leaving patients burdened by high costs and limited access.

Recommended

Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.

Copyright trendadvisor.net
Privacy Policy | Terms of Service